T. B. Tran and T. K. C. Doan, “SOME RISK FACTORS OF CARDIOVASCULAR-METABOLISM AND EVALUATION OF TREATMENT RESULTS WITH EMPAGLIFLOZIN COMBINED METFORMIN IN TYPE 2 DIABETES WITH OVERWEIGHT AND OBESITY”, CTJUMP, no. 33, pp. 10–16, Aug. 2026.